nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC22A3—germ cell cancer	0.464	1	CbGaD
Imipramine—CYP2C18—Ifosfamide—germ cell cancer	0.0862	0.256	CbGbCtD
Imipramine—CYP3A7—Ifosfamide—germ cell cancer	0.0286	0.0851	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0286	0.0851	CbGbCtD
Imipramine—SLC22A2—Vinblastine—germ cell cancer	0.0279	0.0828	CbGbCtD
Imipramine—CYP2B6—Ifosfamide—germ cell cancer	0.0273	0.081	CbGbCtD
Imipramine—SLC22A2—Cisplatin—germ cell cancer	0.0256	0.0759	CbGbCtD
Imipramine—CYP2C19—Ifosfamide—germ cell cancer	0.0173	0.0515	CbGbCtD
Imipramine—CYP2B6—Cisplatin—germ cell cancer	0.0133	0.0394	CbGbCtD
Imipramine—CYP2E1—Etoposide—germ cell cancer	0.0132	0.0393	CbGbCtD
Imipramine—ABCB1—Dactinomycin—germ cell cancer	0.0118	0.0352	CbGbCtD
Imipramine—CYP3A4—Ifosfamide—germ cell cancer	0.00838	0.0249	CbGbCtD
Imipramine—CYP1A2—Etoposide—germ cell cancer	0.00764	0.0227	CbGbCtD
Imipramine—ABCB1—Vinblastine—germ cell cancer	0.00742	0.022	CbGbCtD
Imipramine—CYP2D6—Vinblastine—germ cell cancer	0.00699	0.0208	CbGbCtD
Imipramine—ABCB1—Cisplatin—germ cell cancer	0.0068	0.0202	CbGbCtD
Imipramine—ABCB1—Etoposide—germ cell cancer	0.00668	0.0199	CbGbCtD
Imipramine—CYP3A4—Vinblastine—germ cell cancer	0.00444	0.0132	CbGbCtD
Imipramine—ABCB1—Methotrexate—germ cell cancer	0.00442	0.0131	CbGbCtD
Imipramine—CYP3A4—Etoposide—germ cell cancer	0.004	0.0119	CbGbCtD
Imipramine—HTR2A—appendage—germ cell cancer	0.000454	0.00577	CbGeAlD
Imipramine—SLC22A2—trigeminal ganglion—germ cell cancer	0.000449	0.00571	CbGeAlD
Imipramine—KCND2—medulla oblongata—germ cell cancer	0.000447	0.00568	CbGeAlD
Imipramine—HTR2A—pineal body—germ cell cancer	0.000443	0.00563	CbGeAlD
Imipramine—HTR7—endothelium—germ cell cancer	0.000439	0.00559	CbGeAlD
Imipramine—CYP3A4—urine—germ cell cancer	0.000432	0.00549	CbGeAlD
Imipramine—CYP2D6—urine—germ cell cancer	0.000425	0.0054	CbGeAlD
Imipramine—HTR6—telencephalon—germ cell cancer	0.000423	0.00538	CbGeAlD
Imipramine—KCND3—uterus—germ cell cancer	0.000411	0.00523	CbGeAlD
Imipramine—KCND2—midbrain—germ cell cancer	0.000409	0.00519	CbGeAlD
Imipramine—HTR7—blood vessel—germ cell cancer	0.000405	0.00515	CbGeAlD
Imipramine—CHRM5—eye—germ cell cancer	0.000405	0.00515	CbGeAlD
Imipramine—KCND2—spinal cord—germ cell cancer	0.000399	0.00507	CbGeAlD
Imipramine—KCND2—female gonad—germ cell cancer	0.000386	0.00491	CbGeAlD
Imipramine—SLC22A4—neck—germ cell cancer	0.000386	0.0049	CbGeAlD
Imipramine—KCND3—adrenal gland—germ cell cancer	0.000361	0.00459	CbGeAlD
Imipramine—KCND3—midbrain—germ cell cancer	0.000356	0.00453	CbGeAlD
Imipramine—KCND2—head—germ cell cancer	0.000354	0.0045	CbGeAlD
Imipramine—CHRM5—skin of body—germ cell cancer	0.000352	0.00448	CbGeAlD
Imipramine—KCND2—testis—germ cell cancer	0.000342	0.00435	CbGeAlD
Imipramine—ADRA1D—telencephalon—germ cell cancer	0.00033	0.0042	CbGeAlD
Imipramine—HTR2A—ganglion—germ cell cancer	0.000318	0.00404	CbGeAlD
Imipramine—KCND2—cerebellum—germ cell cancer	0.000316	0.00402	CbGeAlD
Imipramine—KCND3—head—germ cell cancer	0.000309	0.00393	CbGeAlD
Imipramine—SLC22A3—trigeminal ganglion—germ cell cancer	0.000303	0.00385	CbGeAlD
Imipramine—KCND3—testis—germ cell cancer	0.000298	0.00379	CbGeAlD
Imipramine—CHRM4—head—germ cell cancer	0.000294	0.00374	CbGeAlD
Imipramine—SLC22A3—embryo—germ cell cancer	0.000293	0.00372	CbGeAlD
Imipramine—HTR7—neck—germ cell cancer	0.00029	0.00369	CbGeAlD
Imipramine—SLC6A3—brainstem—germ cell cancer	0.000285	0.00362	CbGeAlD
Imipramine—CYP2C18—endocrine gland—germ cell cancer	0.000285	0.00362	CbGeAlD
Imipramine—CHRM4—testis—germ cell cancer	0.000284	0.00361	CbGeAlD
Imipramine—KCND3—cerebellum—germ cell cancer	0.000276	0.0035	CbGeAlD
Imipramine—HTR2C—brainstem—germ cell cancer	0.000275	0.0035	CbGeAlD
Imipramine—HTR2A—endothelium—germ cell cancer	0.000274	0.00348	CbGeAlD
Imipramine—CYP3A7—endocrine gland—germ cell cancer	0.000271	0.00345	CbGeAlD
Imipramine—HTR6—head—germ cell cancer	0.000263	0.00335	CbGeAlD
Imipramine—SLC6A4—brainstem—germ cell cancer	0.000261	0.00332	CbGeAlD
Imipramine—KCND2—brain—germ cell cancer	0.000257	0.00326	CbGeAlD
Imipramine—CHRM2—telencephalon—germ cell cancer	0.000253	0.00322	CbGeAlD
Imipramine—SLC6A3—telencephalon—germ cell cancer	0.000253	0.00321	CbGeAlD
Imipramine—HTR2A—blood vessel—germ cell cancer	0.000253	0.00321	CbGeAlD
Imipramine—SLC22A1—telencephalon—germ cell cancer	0.000249	0.00317	CbGeAlD
Imipramine—SLC22A4—decidua—germ cell cancer	0.000248	0.00315	CbGeAlD
Imipramine—HTR2C—telencephalon—germ cell cancer	0.000244	0.00311	CbGeAlD
Imipramine—KCNH2—trigeminal ganglion—germ cell cancer	0.000233	0.00296	CbGeAlD
Imipramine—HTR1A—brainstem—germ cell cancer	0.000232	0.00295	CbGeAlD
Imipramine—SLC6A4—telencephalon—germ cell cancer	0.000232	0.00295	CbGeAlD
Imipramine—CHRM1—telencephalon—germ cell cancer	0.000231	0.00293	CbGeAlD
Imipramine—CHRM5—head—germ cell cancer	0.00023	0.00292	CbGeAlD
Imipramine—SLC6A2—brainstem—germ cell cancer	0.00023	0.00292	CbGeAlD
Imipramine—Alopecia—Ifosfamide—germ cell cancer	0.000228	0.00277	CcSEcCtD
Imipramine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000227	0.00276	CcSEcCtD
Imipramine—Infestation NOS—Etoposide—germ cell cancer	0.000227	0.00275	CcSEcCtD
Imipramine—Infestation—Etoposide—germ cell cancer	0.000227	0.00275	CcSEcCtD
Imipramine—Mental disorder—Ifosfamide—germ cell cancer	0.000226	0.00274	CcSEcCtD
Imipramine—Malnutrition—Ifosfamide—germ cell cancer	0.000224	0.00273	CcSEcCtD
Imipramine—KCND3—brain—germ cell cancer	0.000224	0.00285	CbGeAlD
Imipramine—Acute coronary syndrome—Etoposide—germ cell cancer	0.000223	0.00272	CcSEcCtD
Imipramine—Neuropathy peripheral—Etoposide—germ cell cancer	0.000222	0.0027	CcSEcCtD
Imipramine—Myocardial infarction—Etoposide—germ cell cancer	0.000222	0.0027	CcSEcCtD
Imipramine—HTR7—brainstem—germ cell cancer	0.000221	0.00282	CbGeAlD
Imipramine—Jaundice—Etoposide—germ cell cancer	0.000221	0.00269	CcSEcCtD
Imipramine—Stomatitis—Etoposide—germ cell cancer	0.000221	0.00269	CcSEcCtD
Imipramine—Discomfort—Bleomycin—germ cell cancer	0.000221	0.00268	CcSEcCtD
Imipramine—Malaise—Dactinomycin—germ cell cancer	0.000221	0.00268	CcSEcCtD
Imipramine—Decreased appetite—Vinblastine—germ cell cancer	0.00022	0.00268	CcSEcCtD
Imipramine—Urinary tract disorder—Cisplatin—germ cell cancer	0.000219	0.00267	CcSEcCtD
Imipramine—Leukopenia—Dactinomycin—germ cell cancer	0.000219	0.00266	CcSEcCtD
Imipramine—Urethral disorder—Cisplatin—germ cell cancer	0.000218	0.00265	CcSEcCtD
Imipramine—Gynaecomastia—Methotrexate—germ cell cancer	0.000217	0.00264	CcSEcCtD
Imipramine—Constipation—Vinblastine—germ cell cancer	0.000217	0.00264	CcSEcCtD
Imipramine—KCND3—lymph node—germ cell cancer	0.000216	0.00275	CbGeAlD
Imipramine—Confusional state—Bleomycin—germ cell cancer	0.000216	0.00262	CcSEcCtD
Imipramine—Hepatobiliary disease—Etoposide—germ cell cancer	0.000214	0.00261	CcSEcCtD
Imipramine—Anaphylactic shock—Bleomycin—germ cell cancer	0.000214	0.0026	CcSEcCtD
Imipramine—Oedema—Bleomycin—germ cell cancer	0.000214	0.0026	CcSEcCtD
Imipramine—ADRA1A—brainstem—germ cell cancer	0.000214	0.00272	CbGeAlD
Imipramine—CHRM4—brain—germ cell cancer	0.000213	0.00271	CbGeAlD
Imipramine—SLC22A4—pituitary gland—germ cell cancer	0.000213	0.00271	CbGeAlD
Imipramine—Infection—Bleomycin—germ cell cancer	0.000213	0.00259	CcSEcCtD
Imipramine—Agranulocytosis—Etoposide—germ cell cancer	0.000211	0.00257	CcSEcCtD
Imipramine—Vision blurred—Ifosfamide—germ cell cancer	0.000211	0.00257	CcSEcCtD
Imipramine—ADRA1B—head—germ cell cancer	0.00021	0.00267	CbGeAlD
Imipramine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00021	0.00255	CcSEcCtD
Imipramine—DRD2—brainstem—germ cell cancer	0.000209	0.00266	CbGeAlD
Imipramine—Feeling abnormal—Vinblastine—germ cell cancer	0.000209	0.00254	CcSEcCtD
Imipramine—ADRA1D—endocrine gland—germ cell cancer	0.000208	0.00265	CbGeAlD
Imipramine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000208	0.00253	CcSEcCtD
Imipramine—Eye disorder—Cisplatin—germ cell cancer	0.000207	0.00252	CcSEcCtD
Imipramine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000207	0.00252	CcSEcCtD
Imipramine—Tinnitus—Cisplatin—germ cell cancer	0.000207	0.00252	CcSEcCtD
Imipramine—CHRM3—telencephalon—germ cell cancer	0.000206	0.00263	CbGeAlD
Imipramine—Cardiac disorder—Cisplatin—germ cell cancer	0.000206	0.00251	CcSEcCtD
Imipramine—Flushing—Cisplatin—germ cell cancer	0.000206	0.00251	CcSEcCtD
Imipramine—Agitation—Ifosfamide—germ cell cancer	0.000206	0.0025	CcSEcCtD
Imipramine—Discomfort—Dactinomycin—germ cell cancer	0.000206	0.0025	CcSEcCtD
Imipramine—HTR1A—telencephalon—germ cell cancer	0.000206	0.00261	CbGeAlD
Imipramine—ADRA1D—head—germ cell cancer	0.000206	0.00261	CbGeAlD
Imipramine—Anorexia—Bleomycin—germ cell cancer	0.000204	0.00248	CcSEcCtD
Imipramine—SLC6A2—telencephalon—germ cell cancer	0.000204	0.00259	CbGeAlD
Imipramine—DRD2—eye—germ cell cancer	0.000204	0.00259	CbGeAlD
Imipramine—Hypoaesthesia—Etoposide—germ cell cancer	0.000202	0.00246	CcSEcCtD
Imipramine—Malaise—Ifosfamide—germ cell cancer	0.000202	0.00246	CcSEcCtD
Imipramine—DRD2—retina—germ cell cancer	0.000202	0.00257	CbGeAlD
Imipramine—Urinary tract disorder—Etoposide—germ cell cancer	0.000201	0.00244	CcSEcCtD
Imipramine—Leukopenia—Ifosfamide—germ cell cancer	0.000201	0.00244	CcSEcCtD
Imipramine—Immune system disorder—Cisplatin—germ cell cancer	0.000201	0.00244	CcSEcCtD
Imipramine—Abdominal pain—Vinblastine—germ cell cancer	0.0002	0.00244	CcSEcCtD
Imipramine—Mediastinal disorder—Cisplatin—germ cell cancer	0.0002	0.00243	CcSEcCtD
Imipramine—Oedema—Dactinomycin—germ cell cancer	0.0002	0.00243	CcSEcCtD
Imipramine—Urethral disorder—Etoposide—germ cell cancer	0.000199	0.00242	CcSEcCtD
Imipramine—SLC22A3—gonad—germ cell cancer	0.000199	0.00253	CbGeAlD
Imipramine—Infection—Dactinomycin—germ cell cancer	0.000198	0.00241	CcSEcCtD
Imipramine—Arrhythmia—Cisplatin—germ cell cancer	0.000198	0.00241	CcSEcCtD
Imipramine—Palpitations—Ifosfamide—germ cell cancer	0.000198	0.00241	CcSEcCtD
Imipramine—HTR7—telencephalon—germ cell cancer	0.000197	0.0025	CbGeAlD
Imipramine—Alopecia—Cisplatin—germ cell cancer	0.000196	0.00239	CcSEcCtD
Imipramine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000195	0.00238	CcSEcCtD
Imipramine—Convulsion—Ifosfamide—germ cell cancer	0.000194	0.00236	CcSEcCtD
Imipramine—Hypertension—Ifosfamide—germ cell cancer	0.000194	0.00235	CcSEcCtD
Imipramine—Malnutrition—Cisplatin—germ cell cancer	0.000193	0.00235	CcSEcCtD
Imipramine—SLC6A2—decidua—germ cell cancer	0.000193	0.00246	CbGeAlD
Imipramine—Paraesthesia—Bleomycin—germ cell cancer	0.000192	0.00234	CcSEcCtD
Imipramine—HTR2C—medulla oblongata—germ cell cancer	0.000192	0.00244	CbGeAlD
Imipramine—ORM1—bone marrow—germ cell cancer	0.000191	0.00243	CbGeAlD
Imipramine—HTR6—brain—germ cell cancer	0.000191	0.00243	CbGeAlD
Imipramine—ORM1—spinal cord—germ cell cancer	0.00019	0.00242	CbGeAlD
Imipramine—Anorexia—Dactinomycin—germ cell cancer	0.00019	0.00231	CcSEcCtD
Imipramine—SLC22A4—adrenal gland—germ cell cancer	0.00019	0.00242	CbGeAlD
Imipramine—Eye disorder—Etoposide—germ cell cancer	0.00019	0.00231	CcSEcCtD
Imipramine—ADRA1A—telencephalon—germ cell cancer	0.00019	0.00241	CbGeAlD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00019	0.0023	CcSEcCtD
Imipramine—Cardiac disorder—Etoposide—germ cell cancer	0.000189	0.0023	CcSEcCtD
Imipramine—Flushing—Etoposide—germ cell cancer	0.000189	0.0023	CcSEcCtD
Imipramine—Discomfort—Ifosfamide—germ cell cancer	0.000189	0.00229	CcSEcCtD
Imipramine—HRH1—trigeminal ganglion—germ cell cancer	0.000187	0.00238	CbGeAlD
Imipramine—Decreased appetite—Bleomycin—germ cell cancer	0.000186	0.00226	CcSEcCtD
Imipramine—DRD2—telencephalon—germ cell cancer	0.000186	0.00236	CbGeAlD
Imipramine—Angiopathy—Etoposide—germ cell cancer	0.000185	0.00224	CcSEcCtD
Imipramine—Confusional state—Ifosfamide—germ cell cancer	0.000184	0.00224	CcSEcCtD
Imipramine—SLC22A4—bone marrow—germ cell cancer	0.000184	0.00234	CbGeAlD
Imipramine—Immune system disorder—Etoposide—germ cell cancer	0.000184	0.00223	CcSEcCtD
Imipramine—Mediastinal disorder—Etoposide—germ cell cancer	0.000183	0.00223	CcSEcCtD
Imipramine—SLC22A4—spinal cord—germ cell cancer	0.000183	0.00233	CbGeAlD
Imipramine—KCNH2—telencephalon—germ cell cancer	0.000183	0.00233	CbGeAlD
Imipramine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000183	0.00222	CcSEcCtD
Imipramine—Oedema—Ifosfamide—germ cell cancer	0.000183	0.00222	CcSEcCtD
Imipramine—Vision blurred—Cisplatin—germ cell cancer	0.000182	0.00221	CcSEcCtD
Imipramine—Asthenia—Vinblastine—germ cell cancer	0.000182	0.00221	CcSEcCtD
Imipramine—Infection—Ifosfamide—germ cell cancer	0.000182	0.00221	CcSEcCtD
Imipramine—SLC6A3—midbrain—germ cell cancer	0.000182	0.00231	CbGeAlD
Imipramine—Tremor—Cisplatin—germ cell cancer	0.000181	0.0022	CcSEcCtD
Imipramine—HTR2A—neck—germ cell cancer	0.000181	0.0023	CbGeAlD
Imipramine—Alopecia—Etoposide—germ cell cancer	0.00018	0.00219	CcSEcCtD
Imipramine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00018	0.00218	CcSEcCtD
Imipramine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000179	0.00218	CcSEcCtD
Imipramine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000179	0.00218	CcSEcCtD
Imipramine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000179	0.00218	CcSEcCtD
Imipramine—Skin disorder—Ifosfamide—germ cell cancer	0.000178	0.00216	CcSEcCtD
Imipramine—SLC6A3—spinal cord—germ cell cancer	0.000177	0.00225	CbGeAlD
Imipramine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000177	0.00215	CcSEcCtD
Imipramine—Feeling abnormal—Bleomycin—germ cell cancer	0.000176	0.00214	CcSEcCtD
Imipramine—HTR2C—midbrain—germ cell cancer	0.000175	0.00223	CbGeAlD
Imipramine—Anorexia—Ifosfamide—germ cell cancer	0.000174	0.00212	CcSEcCtD
Imipramine—Malaise—Cisplatin—germ cell cancer	0.000174	0.00212	CcSEcCtD
Imipramine—Decreased appetite—Dactinomycin—germ cell cancer	0.000174	0.00211	CcSEcCtD
Imipramine—Diarrhoea—Vinblastine—germ cell cancer	0.000173	0.00211	CcSEcCtD
Imipramine—Dysgeusia—Etoposide—germ cell cancer	0.000173	0.00211	CcSEcCtD
Imipramine—SLC22A3—adrenal gland—germ cell cancer	0.000173	0.0022	CbGeAlD
Imipramine—Leukopenia—Cisplatin—germ cell cancer	0.000173	0.0021	CcSEcCtD
Imipramine—Fatigue—Dactinomycin—germ cell cancer	0.000172	0.00209	CcSEcCtD
Imipramine—ORM1—endocrine gland—germ cell cancer	0.000171	0.00218	CbGeAlD
Imipramine—HTR2C—spinal cord—germ cell cancer	0.000171	0.00218	CbGeAlD
Imipramine—SLC6A2—gonad—germ cell cancer	0.00017	0.00216	CbGeAlD
Imipramine—Urticaria—Bleomycin—germ cell cancer	0.00017	0.00207	CcSEcCtD
Imipramine—Body temperature increased—Bleomycin—germ cell cancer	0.000169	0.00206	CcSEcCtD
Imipramine—Dizziness—Vinblastine—germ cell cancer	0.000168	0.00204	CcSEcCtD
Imipramine—Convulsion—Cisplatin—germ cell cancer	0.000167	0.00204	CcSEcCtD
Imipramine—Mood swings—Methotrexate—germ cell cancer	0.000167	0.00203	CcSEcCtD
Imipramine—CHRM5—brain—germ cell cancer	0.000167	0.00212	CbGeAlD
Imipramine—SLC6A4—midbrain—germ cell cancer	0.000166	0.00212	CbGeAlD
Imipramine—Ataxia—Methotrexate—germ cell cancer	0.000166	0.00201	CcSEcCtD
Imipramine—ABCB1—blood vessel—germ cell cancer	0.000166	0.00211	CbGeAlD
Imipramine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000165	0.002	CcSEcCtD
Imipramine—Paraesthesia—Ifosfamide—germ cell cancer	0.000164	0.002	CcSEcCtD
Imipramine—Ill-defined disorder—Etoposide—germ cell cancer	0.000164	0.002	CcSEcCtD
Imipramine—HTR7—gonad—germ cell cancer	0.000164	0.00209	CbGeAlD
Imipramine—Anxiety—Cisplatin—germ cell cancer	0.000164	0.00199	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000163	0.00199	CcSEcCtD
Imipramine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000163	0.00199	CcSEcCtD
Imipramine—Somnolence—Ifosfamide—germ cell cancer	0.000163	0.00198	CcSEcCtD
Imipramine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000163	0.00198	CcSEcCtD
Imipramine—Discomfort—Cisplatin—germ cell cancer	0.000163	0.00198	CcSEcCtD
Imipramine—SLC6A4—spinal cord—germ cell cancer	0.000162	0.00206	CbGeAlD
Imipramine—SLC22A3—female gonad—germ cell cancer	0.000161	0.00205	CbGeAlD
Imipramine—Vomiting—Vinblastine—germ cell cancer	0.000161	0.00196	CcSEcCtD
Imipramine—HRH1—eye—germ cell cancer	0.000161	0.00205	CbGeAlD
Imipramine—SLC6A2—medulla oblongata—germ cell cancer	0.00016	0.00204	CbGeAlD
Imipramine—CHRM2—endocrine gland—germ cell cancer	0.00016	0.00203	CbGeAlD
Imipramine—Malaise—Etoposide—germ cell cancer	0.00016	0.00194	CcSEcCtD
Imipramine—Breast disorder—Methotrexate—germ cell cancer	0.000159	0.00193	CcSEcCtD
Imipramine—Decreased appetite—Ifosfamide—germ cell cancer	0.000159	0.00193	CcSEcCtD
Imipramine—Headache—Vinblastine—germ cell cancer	0.000159	0.00193	CcSEcCtD
Imipramine—Leukopenia—Etoposide—germ cell cancer	0.000158	0.00193	CcSEcCtD
Imipramine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000158	0.00192	CcSEcCtD
Imipramine—CHRM2—head—germ cell cancer	0.000158	0.00201	CbGeAlD
Imipramine—Body temperature increased—Dactinomycin—germ cell cancer	0.000158	0.00192	CcSEcCtD
Imipramine—Abdominal pain—Dactinomycin—germ cell cancer	0.000158	0.00192	CcSEcCtD
Imipramine—Fatigue—Ifosfamide—germ cell cancer	0.000158	0.00192	CcSEcCtD
Imipramine—Oedema—Cisplatin—germ cell cancer	0.000158	0.00192	CcSEcCtD
Imipramine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000158	0.00192	CcSEcCtD
Imipramine—SLC6A3—head—germ cell cancer	0.000157	0.002	CbGeAlD
Imipramine—SLC22A1—endocrine gland—germ cell cancer	0.000157	0.002	CbGeAlD
Imipramine—Infection—Cisplatin—germ cell cancer	0.000157	0.00191	CcSEcCtD
Imipramine—Constipation—Ifosfamide—germ cell cancer	0.000156	0.0019	CcSEcCtD
Imipramine—Loss of consciousness—Etoposide—germ cell cancer	0.000156	0.00189	CcSEcCtD
Imipramine—SLC22A1—head—germ cell cancer	0.000155	0.00197	CbGeAlD
Imipramine—Nervous system disorder—Cisplatin—germ cell cancer	0.000155	0.00188	CcSEcCtD
Imipramine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000154	0.00188	CcSEcCtD
Imipramine—HTR7—medulla oblongata—germ cell cancer	0.000154	0.00196	CbGeAlD
Imipramine—Tachycardia—Cisplatin—germ cell cancer	0.000154	0.00187	CcSEcCtD
Imipramine—Asthenia—Bleomycin—germ cell cancer	0.000154	0.00187	CcSEcCtD
Imipramine—Convulsion—Etoposide—germ cell cancer	0.000153	0.00187	CcSEcCtD
Imipramine—Skin disorder—Cisplatin—germ cell cancer	0.000153	0.00186	CcSEcCtD
Imipramine—Hypertension—Etoposide—germ cell cancer	0.000153	0.00186	CcSEcCtD
Imipramine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000152	0.00185	CcSEcCtD
Imipramine—ADRA1B—brain—germ cell cancer	0.000152	0.00194	CbGeAlD
Imipramine—HTR2C—head—germ cell cancer	0.000152	0.00193	CbGeAlD
Imipramine—SLC6A3—testis—germ cell cancer	0.000152	0.00193	CbGeAlD
Imipramine—KCNH2—uterus—germ cell cancer	0.000152	0.00193	CbGeAlD
Imipramine—Pruritus—Bleomycin—germ cell cancer	0.000151	0.00184	CcSEcCtD
Imipramine—DRD2—pituitary gland—germ cell cancer	0.000151	0.00192	CbGeAlD
Imipramine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000151	0.00183	CcSEcCtD
Imipramine—Eosinophilia—Methotrexate—germ cell cancer	0.000151	0.00183	CcSEcCtD
Imipramine—HTR2A—embryo—germ cell cancer	0.000151	0.00192	CbGeAlD
Imipramine—Nausea—Vinblastine—germ cell cancer	0.000151	0.00183	CcSEcCtD
Imipramine—Anorexia—Cisplatin—germ cell cancer	0.00015	0.00183	CcSEcCtD
Imipramine—SLC22A3—endocrine gland—germ cell cancer	0.00015	0.00191	CbGeAlD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00015	0.00182	CcSEcCtD
Imipramine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00015	0.00182	CcSEcCtD
Imipramine—HTR1A—adrenal gland—germ cell cancer	0.00015	0.0019	CbGeAlD
Imipramine—KCNH2—pituitary gland—germ cell cancer	0.000149	0.0019	CbGeAlD
Imipramine—ADRA1D—brain—germ cell cancer	0.000149	0.00189	CbGeAlD
Imipramine—Discomfort—Etoposide—germ cell cancer	0.000149	0.00181	CcSEcCtD
Imipramine—SLC6A2—adrenal gland—germ cell cancer	0.000148	0.00189	CbGeAlD
Imipramine—SLC22A3—head—germ cell cancer	0.000148	0.00188	CbGeAlD
Imipramine—HTR1A—midbrain—germ cell cancer	0.000148	0.00188	CbGeAlD
Imipramine—HRH1—telencephalon—germ cell cancer	0.000147	0.00187	CbGeAlD
Imipramine—SLC6A4—endocrine gland—germ cell cancer	0.000146	0.00186	CbGeAlD
Imipramine—Confusional state—Etoposide—germ cell cancer	0.000146	0.00177	CcSEcCtD
Imipramine—CHRM1—endocrine gland—germ cell cancer	0.000146	0.00185	CbGeAlD
Imipramine—Urticaria—Ifosfamide—germ cell cancer	0.000145	0.00177	CcSEcCtD
Imipramine—SLC22A4—cerebellum—germ cell cancer	0.000145	0.00185	CbGeAlD
Imipramine—Body temperature increased—Ifosfamide—germ cell cancer	0.000145	0.00176	CcSEcCtD
Imipramine—Abdominal pain—Ifosfamide—germ cell cancer	0.000145	0.00176	CcSEcCtD
Imipramine—Pancytopenia—Methotrexate—germ cell cancer	0.000145	0.00176	CcSEcCtD
Imipramine—Anaphylactic shock—Etoposide—germ cell cancer	0.000145	0.00176	CcSEcCtD
Imipramine—SLC6A4—head—germ cell cancer	0.000144	0.00183	CbGeAlD
Imipramine—HTR1A—spinal cord—germ cell cancer	0.000144	0.00183	CbGeAlD
Imipramine—KCNH2—medulla oblongata—germ cell cancer	0.000144	0.00183	CbGeAlD
Imipramine—CHRM1—head—germ cell cancer	0.000144	0.00183	CbGeAlD
Imipramine—Infection—Etoposide—germ cell cancer	0.000144	0.00175	CcSEcCtD
Imipramine—CYP2B6—skin of body—germ cell cancer	0.000143	0.00182	CbGeAlD
Imipramine—Asthenia—Dactinomycin—germ cell cancer	0.000143	0.00174	CcSEcCtD
Imipramine—SLC22A3—testis—germ cell cancer	0.000143	0.00182	CbGeAlD
Imipramine—HTR7—adrenal gland—germ cell cancer	0.000143	0.00182	CbGeAlD
Imipramine—Paraesthesia—Cisplatin—germ cell cancer	0.000142	0.00172	CcSEcCtD
Imipramine—Thrombocytopenia—Etoposide—germ cell cancer	0.000141	0.00172	CcSEcCtD
Imipramine—HTR7—midbrain—germ cell cancer	0.000141	0.00179	CbGeAlD
Imipramine—Tachycardia—Etoposide—germ cell cancer	0.000141	0.00171	CcSEcCtD
Imipramine—CYP2E1—telencephalon—germ cell cancer	0.000141	0.00179	CbGeAlD
Imipramine—SLC6A3—cerebellum—germ cell cancer	0.00014	0.00179	CbGeAlD
Imipramine—Skin disorder—Etoposide—germ cell cancer	0.00014	0.00171	CcSEcCtD
Imipramine—Erectile dysfunction—Methotrexate—germ cell cancer	0.00014	0.0017	CcSEcCtD
Imipramine—CHRM3—female gonad—germ cell cancer	0.00014	0.00178	CbGeAlD
Imipramine—Hyperhidrosis—Etoposide—germ cell cancer	0.00014	0.0017	CcSEcCtD
Imipramine—HRH1—decidua—germ cell cancer	0.000139	0.00177	CbGeAlD
Imipramine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000139	0.00169	CcSEcCtD
Imipramine—HTR2A—brainstem—germ cell cancer	0.000138	0.00176	CbGeAlD
Imipramine—ADRA1A—adrenal gland—germ cell cancer	0.000138	0.00175	CbGeAlD
Imipramine—Anorexia—Etoposide—germ cell cancer	0.000138	0.00167	CcSEcCtD
Imipramine—HTR7—spinal cord—germ cell cancer	0.000138	0.00175	CbGeAlD
Imipramine—Decreased appetite—Cisplatin—germ cell cancer	0.000137	0.00167	CcSEcCtD
Imipramine—Diarrhoea—Dactinomycin—germ cell cancer	0.000137	0.00166	CcSEcCtD
Imipramine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000136	0.00166	CcSEcCtD
Imipramine—Vomiting—Bleomycin—germ cell cancer	0.000136	0.00165	CcSEcCtD
Imipramine—Drowsiness—Methotrexate—germ cell cancer	0.000136	0.00165	CcSEcCtD
Imipramine—Infestation NOS—Methotrexate—germ cell cancer	0.000136	0.00165	CcSEcCtD
Imipramine—Infestation—Methotrexate—germ cell cancer	0.000136	0.00165	CcSEcCtD
Imipramine—Rash—Bleomycin—germ cell cancer	0.000135	0.00164	CcSEcCtD
Imipramine—Dermatitis—Bleomycin—germ cell cancer	0.000135	0.00164	CcSEcCtD
Imipramine—HTR2A—eye—germ cell cancer	0.000134	0.00171	CbGeAlD
Imipramine—DRD2—midbrain—germ cell cancer	0.000133	0.0017	CbGeAlD
Imipramine—HTR2A—retina—germ cell cancer	0.000133	0.00169	CbGeAlD
Imipramine—KCNH2—adrenal gland—germ cell cancer	0.000133	0.00169	CbGeAlD
Imipramine—Stomatitis—Methotrexate—germ cell cancer	0.000132	0.00161	CcSEcCtD
Imipramine—KCNH2—midbrain—germ cell cancer	0.000131	0.00167	CbGeAlD
Imipramine—Asthenia—Ifosfamide—germ cell cancer	0.000131	0.0016	CcSEcCtD
Imipramine—CHRM3—endocrine gland—germ cell cancer	0.00013	0.00166	CbGeAlD
Imipramine—Feeling abnormal—Cisplatin—germ cell cancer	0.00013	0.00158	CcSEcCtD
Imipramine—Paraesthesia—Etoposide—germ cell cancer	0.00013	0.00158	CcSEcCtD
Imipramine—HTR1A—endocrine gland—germ cell cancer	0.00013	0.00165	CbGeAlD
Imipramine—Pruritus—Ifosfamide—germ cell cancer	0.000129	0.00157	CcSEcCtD
Imipramine—KCNH2—bone marrow—germ cell cancer	0.000129	0.00164	CbGeAlD
Imipramine—SLC6A2—endocrine gland—germ cell cancer	0.000129	0.00164	CbGeAlD
Imipramine—CHRM3—head—germ cell cancer	0.000129	0.00163	CbGeAlD
Imipramine—Somnolence—Etoposide—germ cell cancer	0.000128	0.00156	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000128	0.00156	CcSEcCtD
Imipramine—KCNH2—spinal cord—germ cell cancer	0.000128	0.00163	CbGeAlD
Imipramine—HTR1A—head—germ cell cancer	0.000128	0.00163	CbGeAlD
Imipramine—Nausea—Bleomycin—germ cell cancer	0.000127	0.00155	CcSEcCtD
Imipramine—SLC6A2—head—germ cell cancer	0.000127	0.00161	CbGeAlD
Imipramine—Vomiting—Dactinomycin—germ cell cancer	0.000127	0.00154	CcSEcCtD
Imipramine—Agranulocytosis—Methotrexate—germ cell cancer	0.000127	0.00154	CcSEcCtD
Imipramine—Rash—Dactinomycin—germ cell cancer	0.000126	0.00153	CcSEcCtD
Imipramine—CYP2D6—brainstem—germ cell cancer	0.000126	0.0016	CbGeAlD
Imipramine—Decreased appetite—Etoposide—germ cell cancer	0.000126	0.00153	CcSEcCtD
Imipramine—CYP2B6—gonad—germ cell cancer	0.000125	0.00159	CbGeAlD
Imipramine—Diarrhoea—Ifosfamide—germ cell cancer	0.000125	0.00152	CcSEcCtD
Imipramine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000125	0.00152	CcSEcCtD
Imipramine—Body temperature increased—Cisplatin—germ cell cancer	0.000125	0.00152	CcSEcCtD
Imipramine—Fatigue—Etoposide—germ cell cancer	0.000125	0.00151	CcSEcCtD
Imipramine—CHRM3—testis—germ cell cancer	0.000124	0.00158	CbGeAlD
Imipramine—KCNH2—female gonad—germ cell cancer	0.000124	0.00158	CbGeAlD
Imipramine—HTR7—endocrine gland—germ cell cancer	0.000124	0.00158	CbGeAlD
Imipramine—Constipation—Etoposide—germ cell cancer	0.000124	0.0015	CcSEcCtD
Imipramine—SLC6A2—testis—germ cell cancer	0.000123	0.00156	CbGeAlD
Imipramine—HTR2A—telencephalon—germ cell cancer	0.000123	0.00156	CbGeAlD
Imipramine—HTR7—head—germ cell cancer	0.000122	0.00156	CbGeAlD
Imipramine—Hepatitis—Methotrexate—germ cell cancer	0.000122	0.00148	CcSEcCtD
Imipramine—CYP2C19—endocrine gland—germ cell cancer	0.000121	0.00154	CbGeAlD
Imipramine—Dizziness—Ifosfamide—germ cell cancer	0.000121	0.00147	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—germ cell cancer	0.00012	0.00146	CcSEcCtD
Imipramine—ADRA1A—endocrine gland—germ cell cancer	0.00012	0.00152	CbGeAlD
Imipramine—Urethral disorder—Methotrexate—germ cell cancer	0.000119	0.00145	CcSEcCtD
Imipramine—Feeling abnormal—Etoposide—germ cell cancer	0.000119	0.00145	CcSEcCtD
Imipramine—Nausea—Dactinomycin—germ cell cancer	0.000119	0.00144	CcSEcCtD
Imipramine—ORM1—lymph node—germ cell cancer	0.000119	0.00151	CbGeAlD
Imipramine—HTR7—testis—germ cell cancer	0.000118	0.0015	CbGeAlD
Imipramine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000118	0.00144	CcSEcCtD
Imipramine—ADRA1A—head—germ cell cancer	0.000118	0.0015	CbGeAlD
Imipramine—SLC22A4—brain—germ cell cancer	0.000118	0.0015	CbGeAlD
Imipramine—DRD2—endocrine gland—germ cell cancer	0.000117	0.00149	CbGeAlD
Imipramine—Vomiting—Ifosfamide—germ cell cancer	0.000116	0.00141	CcSEcCtD
Imipramine—DRD2—head—germ cell cancer	0.000116	0.00147	CbGeAlD
Imipramine—KCNH2—endocrine gland—germ cell cancer	0.000115	0.00147	CbGeAlD
Imipramine—Rash—Ifosfamide—germ cell cancer	0.000115	0.0014	CcSEcCtD
Imipramine—Dermatitis—Ifosfamide—germ cell cancer	0.000115	0.0014	CcSEcCtD
Imipramine—Urticaria—Etoposide—germ cell cancer	0.000115	0.0014	CcSEcCtD
Imipramine—CHRM2—brain—germ cell cancer	0.000114	0.00145	CbGeAlD
Imipramine—HTR1A—cerebellum—germ cell cancer	0.000114	0.00145	CbGeAlD
Imipramine—Body temperature increased—Etoposide—germ cell cancer	0.000114	0.00139	CcSEcCtD
Imipramine—Abdominal pain—Etoposide—germ cell cancer	0.000114	0.00139	CcSEcCtD
Imipramine—SLC6A3—brain—germ cell cancer	0.000114	0.00145	CbGeAlD
Imipramine—SLC22A4—lymph node—germ cell cancer	0.000114	0.00145	CbGeAlD
Imipramine—KCNH2—head—germ cell cancer	0.000114	0.00145	CbGeAlD
Imipramine—Eye disorder—Methotrexate—germ cell cancer	0.000114	0.00138	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—germ cell cancer	0.000114	0.00138	CcSEcCtD
Imipramine—Asthenia—Cisplatin—germ cell cancer	0.000113	0.00138	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—germ cell cancer	0.000113	0.00137	CcSEcCtD
Imipramine—SLC22A1—brain—germ cell cancer	0.000112	0.00143	CbGeAlD
Imipramine—DRD2—testis—germ cell cancer	0.000112	0.00142	CbGeAlD
Imipramine—CYP2D6—telencephalon—germ cell cancer	0.000112	0.00142	CbGeAlD
Imipramine—CYP2E1—medulla oblongata—germ cell cancer	0.000111	0.00141	CbGeAlD
Imipramine—Angiopathy—Methotrexate—germ cell cancer	0.000111	0.00134	CcSEcCtD
Imipramine—HTR2C—brain—germ cell cancer	0.00011	0.0014	CbGeAlD
Imipramine—KCNH2—testis—germ cell cancer	0.00011	0.0014	CbGeAlD
Imipramine—Immune system disorder—Methotrexate—germ cell cancer	0.00011	0.00134	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00011	0.00133	CcSEcCtD
Imipramine—CYP2B6—adrenal gland—germ cell cancer	0.000109	0.00139	CbGeAlD
Imipramine—HTR7—cerebellum—germ cell cancer	0.000109	0.00139	CbGeAlD
Imipramine—Nausea—Ifosfamide—germ cell cancer	0.000109	0.00132	CcSEcCtD
Imipramine—Diarrhoea—Cisplatin—germ cell cancer	0.000108	0.00131	CcSEcCtD
Imipramine—Alopecia—Methotrexate—germ cell cancer	0.000108	0.00131	CcSEcCtD
Imipramine—SLC22A3—brain—germ cell cancer	0.000107	0.00137	CbGeAlD
Imipramine—Mental disorder—Methotrexate—germ cell cancer	0.000107	0.0013	CcSEcCtD
Imipramine—HRH1—adrenal gland—germ cell cancer	0.000107	0.00136	CbGeAlD
Imipramine—Malnutrition—Methotrexate—germ cell cancer	0.000106	0.00129	CcSEcCtD
Imipramine—ADRA1A—cerebellum—germ cell cancer	0.000105	0.00134	CbGeAlD
Imipramine—SLC6A4—brain—germ cell cancer	0.000105	0.00133	CbGeAlD
Imipramine—CHRM1—brain—germ cell cancer	0.000104	0.00132	CbGeAlD
Imipramine—Dysgeusia—Methotrexate—germ cell cancer	0.000104	0.00126	CcSEcCtD
Imipramine—SLC22A3—lymph node—germ cell cancer	0.000104	0.00132	CbGeAlD
Imipramine—Asthenia—Etoposide—germ cell cancer	0.000104	0.00126	CcSEcCtD
Imipramine—DRD2—cerebellum—germ cell cancer	0.000103	0.00131	CbGeAlD
Imipramine—CYP2E1—adrenal gland—germ cell cancer	0.000103	0.0013	CbGeAlD
Imipramine—HTR2A—gonad—germ cell cancer	0.000102	0.0013	CbGeAlD
Imipramine—ABCB1—trigeminal ganglion—germ cell cancer	0.000102	0.0013	CbGeAlD
Imipramine—Pruritus—Etoposide—germ cell cancer	0.000102	0.00124	CcSEcCtD
Imipramine—KCNH2—cerebellum—germ cell cancer	0.000102	0.00129	CbGeAlD
Imipramine—Vomiting—Cisplatin—germ cell cancer	0.0001	0.00122	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—germ cell cancer	9.99e-05	0.00122	CcSEcCtD
Imipramine—HTR2A—pituitary gland—germ cell cancer	9.98e-05	0.00127	CbGeAlD
Imipramine—HRH1—female gonad—germ cell cancer	9.95e-05	0.00127	CbGeAlD
Imipramine—Rash—Cisplatin—germ cell cancer	9.95e-05	0.00121	CcSEcCtD
Imipramine—Dermatitis—Cisplatin—germ cell cancer	9.94e-05	0.00121	CcSEcCtD
Imipramine—Diarrhoea—Etoposide—germ cell cancer	9.89e-05	0.0012	CcSEcCtD
Imipramine—CYP1A2—endocrine gland—germ cell cancer	9.89e-05	0.00126	CbGeAlD
Imipramine—CYP2E1—spinal cord—germ cell cancer	9.88e-05	0.00126	CbGeAlD
Imipramine—ABCB1—embryo—germ cell cancer	9.88e-05	0.00126	CbGeAlD
Imipramine—Ill-defined disorder—Methotrexate—germ cell cancer	9.84e-05	0.0012	CcSEcCtD
Imipramine—HTR2A—medulla oblongata—germ cell cancer	9.63e-05	0.00122	CbGeAlD
Imipramine—Malaise—Methotrexate—germ cell cancer	9.56e-05	0.00116	CcSEcCtD
Imipramine—Dizziness—Etoposide—germ cell cancer	9.56e-05	0.00116	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—germ cell cancer	9.49e-05	0.00115	CcSEcCtD
Imipramine—CYP2B6—endocrine gland—germ cell cancer	9.48e-05	0.00121	CbGeAlD
Imipramine—Nausea—Cisplatin—germ cell cancer	9.37e-05	0.00114	CcSEcCtD
Imipramine—CYP2B6—head—germ cell cancer	9.36e-05	0.00119	CbGeAlD
Imipramine—CHRM3—brain—germ cell cancer	9.32e-05	0.00118	CbGeAlD
Imipramine—HTR1A—brain—germ cell cancer	9.28e-05	0.00118	CbGeAlD
Imipramine—HRH1—endocrine gland—germ cell cancer	9.26e-05	0.00118	CbGeAlD
Imipramine—SLC6A2—brain—germ cell cancer	9.2e-05	0.00117	CbGeAlD
Imipramine—Convulsion—Methotrexate—germ cell cancer	9.19e-05	0.00112	CcSEcCtD
Imipramine—Vomiting—Etoposide—germ cell cancer	9.19e-05	0.00112	CcSEcCtD
Imipramine—HRH1—head—germ cell cancer	9.14e-05	0.00116	CbGeAlD
Imipramine—Rash—Etoposide—germ cell cancer	9.11e-05	0.00111	CcSEcCtD
Imipramine—Dermatitis—Etoposide—germ cell cancer	9.1e-05	0.00111	CcSEcCtD
Imipramine—Headache—Etoposide—germ cell cancer	9.05e-05	0.0011	CcSEcCtD
Imipramine—CYP2B6—testis—germ cell cancer	9.04e-05	0.00115	CbGeAlD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	8.97e-05	0.00109	CcSEcCtD
Imipramine—Discomfort—Methotrexate—germ cell cancer	8.92e-05	0.00108	CcSEcCtD
Imipramine—HTR2A—adrenal gland—germ cell cancer	8.91e-05	0.00113	CbGeAlD
Imipramine—CYP2E1—endocrine gland—germ cell cancer	8.89e-05	0.00113	CbGeAlD
Imipramine—SLC6A2—lymph node—germ cell cancer	8.89e-05	0.00113	CbGeAlD
Imipramine—HTR7—brain—germ cell cancer	8.87e-05	0.00113	CbGeAlD
Imipramine—HRH1—testis—germ cell cancer	8.83e-05	0.00112	CbGeAlD
Imipramine—HTR2A—midbrain—germ cell cancer	8.8e-05	0.00112	CbGeAlD
Imipramine—CYP2E1—head—germ cell cancer	8.78e-05	0.00112	CbGeAlD
Imipramine—ABCB1—retina—germ cell cancer	8.73e-05	0.00111	CbGeAlD
Imipramine—Confusional state—Methotrexate—germ cell cancer	8.73e-05	0.00106	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—germ cell cancer	8.66e-05	0.00105	CcSEcCtD
Imipramine—Infection—Methotrexate—germ cell cancer	8.6e-05	0.00105	CcSEcCtD
Imipramine—HTR2A—spinal cord—germ cell cancer	8.59e-05	0.00109	CbGeAlD
Imipramine—Nausea—Etoposide—germ cell cancer	8.58e-05	0.00104	CcSEcCtD
Imipramine—ADRA1A—brain—germ cell cancer	8.55e-05	0.00109	CbGeAlD
Imipramine—Nervous system disorder—Methotrexate—germ cell cancer	8.49e-05	0.00103	CcSEcCtD
Imipramine—CYP2E1—testis—germ cell cancer	8.48e-05	0.00108	CbGeAlD
Imipramine—Thrombocytopenia—Methotrexate—germ cell cancer	8.47e-05	0.00103	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—germ cell cancer	8.41e-05	0.00102	CcSEcCtD
Imipramine—DRD2—brain—germ cell cancer	8.38e-05	0.00107	CbGeAlD
Imipramine—Hyperhidrosis—Methotrexate—germ cell cancer	8.37e-05	0.00102	CcSEcCtD
Imipramine—KCNH2—brain—germ cell cancer	8.26e-05	0.00105	CbGeAlD
Imipramine—Anorexia—Methotrexate—germ cell cancer	8.25e-05	0.001	CcSEcCtD
Imipramine—ABCB1—telencephalon—germ cell cancer	8.03e-05	0.00102	CbGeAlD
Imipramine—KCNH2—lymph node—germ cell cancer	7.98e-05	0.00102	CbGeAlD
Imipramine—CYP2E1—cerebellum—germ cell cancer	7.83e-05	0.000996	CbGeAlD
Imipramine—Insomnia—Methotrexate—germ cell cancer	7.83e-05	0.000952	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—germ cell cancer	7.77e-05	0.000945	CcSEcCtD
Imipramine—HTR2A—endocrine gland—germ cell cancer	7.73e-05	0.000983	CbGeAlD
Imipramine—Somnolence—Methotrexate—germ cell cancer	7.69e-05	0.000936	CcSEcCtD
Imipramine—HTR2A—head—germ cell cancer	7.63e-05	0.00097	CbGeAlD
Imipramine—Dyspepsia—Methotrexate—germ cell cancer	7.62e-05	0.000926	CcSEcCtD
Imipramine—ABCB1—decidua—germ cell cancer	7.61e-05	0.000968	CbGeAlD
Imipramine—CYP2D6—female gonad—germ cell cancer	7.57e-05	0.000963	CbGeAlD
Imipramine—Decreased appetite—Methotrexate—germ cell cancer	7.52e-05	0.000915	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—germ cell cancer	7.47e-05	0.000909	CcSEcCtD
Imipramine—Fatigue—Methotrexate—germ cell cancer	7.46e-05	0.000907	CcSEcCtD
Imipramine—HTR2A—testis—germ cell cancer	7.37e-05	0.000937	CbGeAlD
Imipramine—CYP3A4—endocrine gland—germ cell cancer	7.16e-05	0.00091	CbGeAlD
Imipramine—Feeling abnormal—Methotrexate—germ cell cancer	7.13e-05	0.000867	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—germ cell cancer	7.08e-05	0.000861	CcSEcCtD
Imipramine—CYP2D6—endocrine gland—germ cell cancer	7.04e-05	0.000895	CbGeAlD
Imipramine—CYP2D6—head—germ cell cancer	6.95e-05	0.000884	CbGeAlD
Imipramine—Urticaria—Methotrexate—germ cell cancer	6.88e-05	0.000836	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—germ cell cancer	6.84e-05	0.000832	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—germ cell cancer	6.84e-05	0.000832	CcSEcCtD
Imipramine—HTR2A—cerebellum—germ cell cancer	6.81e-05	0.000866	CbGeAlD
Imipramine—CYP2B6—brain—germ cell cancer	6.78e-05	0.000862	CbGeAlD
Imipramine—CYP2D6—testis—germ cell cancer	6.72e-05	0.000854	CbGeAlD
Imipramine—ABCB1—gonad—germ cell cancer	6.7e-05	0.000852	CbGeAlD
Imipramine—ABCB1—uterus—germ cell cancer	6.66e-05	0.000847	CbGeAlD
Imipramine—HRH1—brain—germ cell cancer	6.62e-05	0.000842	CbGeAlD
Imipramine—ABCB1—pituitary gland—germ cell cancer	6.54e-05	0.000832	CbGeAlD
Imipramine—HRH1—lymph node—germ cell cancer	6.4e-05	0.000814	CbGeAlD
Imipramine—CYP2E1—brain—germ cell cancer	6.36e-05	0.000809	CbGeAlD
Imipramine—ABCB1—medulla oblongata—germ cell cancer	6.31e-05	0.000802	CbGeAlD
Imipramine—Asthenia—Methotrexate—germ cell cancer	6.21e-05	0.000755	CcSEcCtD
Imipramine—CYP2D6—cerebellum—germ cell cancer	6.2e-05	0.000789	CbGeAlD
Imipramine—Pruritus—Methotrexate—germ cell cancer	6.12e-05	0.000745	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—germ cell cancer	5.92e-05	0.00072	CcSEcCtD
Imipramine—ABCB1—adrenal gland—germ cell cancer	5.84e-05	0.000743	CbGeAlD
Imipramine—ABCB1—midbrain—germ cell cancer	5.77e-05	0.000733	CbGeAlD
Imipramine—Dizziness—Methotrexate—germ cell cancer	5.72e-05	0.000696	CcSEcCtD
Imipramine—ABCB1—bone marrow—germ cell cancer	5.65e-05	0.000719	CbGeAlD
Imipramine—ABCB1—spinal cord—germ cell cancer	5.63e-05	0.000716	CbGeAlD
Imipramine—HTR2A—brain—germ cell cancer	5.53e-05	0.000703	CbGeAlD
Imipramine—Vomiting—Methotrexate—germ cell cancer	5.5e-05	0.000669	CcSEcCtD
Imipramine—Rash—Methotrexate—germ cell cancer	5.46e-05	0.000664	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—germ cell cancer	5.45e-05	0.000663	CcSEcCtD
Imipramine—ABCB1—female gonad—germ cell cancer	5.45e-05	0.000693	CbGeAlD
Imipramine—Headache—Methotrexate—germ cell cancer	5.42e-05	0.000659	CcSEcCtD
Imipramine—Nausea—Methotrexate—germ cell cancer	5.14e-05	0.000625	CcSEcCtD
Imipramine—ABCB1—endocrine gland—germ cell cancer	5.07e-05	0.000644	CbGeAlD
Imipramine—CYP2D6—brain—germ cell cancer	5.04e-05	0.000641	CbGeAlD
Imipramine—ABCB1—head—germ cell cancer	5e-05	0.000636	CbGeAlD
Imipramine—ABCB1—testis—germ cell cancer	4.83e-05	0.000614	CbGeAlD
Imipramine—ABCB1—cerebellum—germ cell cancer	4.46e-05	0.000567	CbGeAlD
Imipramine—ABCB1—brain—germ cell cancer	3.62e-05	0.000461	CbGeAlD
Imipramine—ABCB1—lymph node—germ cell cancer	3.5e-05	0.000445	CbGeAlD
Imipramine—CHRM2—GPCR downstream signaling—OXT—germ cell cancer	1.69e-05	0.000445	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—OXT—germ cell cancer	1.69e-05	0.000444	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—AVP—germ cell cancer	1.68e-05	0.000441	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—AVP—germ cell cancer	1.68e-05	0.000441	CbGpPWpGaD
Imipramine—KCNH2—Neuronal System—HRAS—germ cell cancer	1.68e-05	0.000441	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—AVP—germ cell cancer	1.67e-05	0.000439	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—SLC2A3—germ cell cancer	1.63e-05	0.000429	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—SLC22A3—germ cell cancer	1.61e-05	0.000422	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—OXT—germ cell cancer	1.59e-05	0.000419	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—AVP—germ cell cancer	1.58e-05	0.000416	CbGpPWpGaD
Imipramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.58e-05	0.000416	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—AVP—germ cell cancer	1.57e-05	0.000413	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—OXT—germ cell cancer	1.57e-05	0.000412	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—OXT—germ cell cancer	1.56e-05	0.000411	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—OXT—germ cell cancer	1.56e-05	0.00041	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—OXT—germ cell cancer	1.55e-05	0.000408	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—OXT—germ cell cancer	1.54e-05	0.000404	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—OXT—germ cell cancer	1.53e-05	0.000403	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—CRABP1—germ cell cancer	1.52e-05	0.000401	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—CRABP1—germ cell cancer	1.52e-05	0.0004	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—AVP—germ cell cancer	1.52e-05	0.000399	CbGpPWpGaD
Imipramine—SLC6A3—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.5e-05	0.000395	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.49e-05	0.000392	CbGpPWpGaD
Imipramine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.49e-05	0.000391	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—OXT—germ cell cancer	1.45e-05	0.000381	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—OXT—germ cell cancer	1.45e-05	0.00038	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—AVP—germ cell cancer	1.43e-05	0.000375	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—CRABP1—germ cell cancer	1.42e-05	0.000373	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—SLC2A3—germ cell cancer	1.4e-05	0.000369	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—SLC22A3—germ cell cancer	1.38e-05	0.000363	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—SLC2A3—germ cell cancer	1.37e-05	0.000361	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AVP—germ cell cancer	1.37e-05	0.00036	CbGpPWpGaD
Imipramine—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.37e-05	0.000359	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—OXT—germ cell cancer	1.36e-05	0.000359	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AVP—germ cell cancer	1.36e-05	0.000358	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—SLC22A3—germ cell cancer	1.35e-05	0.000356	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CRABP1—germ cell cancer	1.31e-05	0.000344	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—OXT—germ cell cancer	1.31e-05	0.000344	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AVP—germ cell cancer	1.3e-05	0.000343	CbGpPWpGaD
Imipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.29e-05	0.000339	CbGpPWpGaD
Imipramine—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.27e-05	0.000335	CbGpPWpGaD
Imipramine—DRD2—Circadian rythm related genes—TP53—germ cell cancer	1.26e-05	0.00033	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AVP—germ cell cancer	1.24e-05	0.000327	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AVP—germ cell cancer	1.24e-05	0.000325	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—FGF4—germ cell cancer	1.23e-05	0.000325	CbGpPWpGaD
Imipramine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.23e-05	0.000324	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—FGF4—germ cell cancer	1.23e-05	0.000324	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—OXT—germ cell cancer	1.23e-05	0.000323	CbGpPWpGaD
Imipramine—CHRM1—Circadian rythm related genes—TP53—germ cell cancer	1.23e-05	0.000323	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AVP—germ cell cancer	1.2e-05	0.000316	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AVP—germ cell cancer	1.18e-05	0.000311	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AVP—germ cell cancer	1.18e-05	0.000311	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AVP—germ cell cancer	1.18e-05	0.00031	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AVP—germ cell cancer	1.18e-05	0.000309	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AVP—germ cell cancer	1.17e-05	0.000308	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—FGF4—germ cell cancer	1.16e-05	0.000306	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AVP—germ cell cancer	1.16e-05	0.000305	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AVP—germ cell cancer	1.16e-05	0.000304	CbGpPWpGaD
Imipramine—SLC6A3—Neuronal System—HRAS—germ cell cancer	1.15e-05	0.000302	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CRABP1—germ cell cancer	1.13e-05	0.000296	CbGpPWpGaD
Imipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.12e-05	0.000294	CbGpPWpGaD
Imipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.12e-05	0.000294	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—FGF4—germ cell cancer	1.12e-05	0.000293	CbGpPWpGaD
Imipramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.11e-05	0.000293	CbGpPWpGaD
Imipramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.11e-05	0.000292	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CRABP1—germ cell cancer	1.1e-05	0.00029	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—H2AFZ—germ cell cancer	1.1e-05	0.00029	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—H2AFZ—germ cell cancer	1.1e-05	0.00029	CbGpPWpGaD
Imipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.1e-05	0.000288	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AVP—germ cell cancer	1.09e-05	0.000287	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AVP—germ cell cancer	1.07e-05	0.000282	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AVP—germ cell cancer	1.07e-05	0.000282	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—OXT—germ cell cancer	1.07e-05	0.000282	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AVP—germ cell cancer	1.07e-05	0.000281	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—OXT—germ cell cancer	1.07e-05	0.00028	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AVP—germ cell cancer	1.06e-05	0.00028	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—SLC2A3—germ cell cancer	1.06e-05	0.000279	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AVP—germ cell cancer	1.05e-05	0.000277	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AVP—germ cell cancer	1.05e-05	0.000276	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—FGF4—germ cell cancer	1.05e-05	0.000276	CbGpPWpGaD
Imipramine—SLC22A2—Neuronal System—HRAS—germ cell cancer	1.05e-05	0.000275	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—SLC22A3—germ cell cancer	1.04e-05	0.000275	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—H2AFZ—germ cell cancer	1.04e-05	0.000274	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.03e-05	0.000272	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—OXT—germ cell cancer	1.02e-05	0.000268	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.02e-05	0.000268	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.02e-05	0.000268	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—KITLG—germ cell cancer	1.01e-05	0.000267	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—KITLG—germ cell cancer	1.01e-05	0.000267	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—H2AFZ—germ cell cancer	9.96e-06	0.000262	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AVP—germ cell cancer	9.91e-06	0.000261	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AVP—germ cell cancer	9.9e-06	0.000261	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	9.85e-06	0.000259	CbGpPWpGaD
Imipramine—SLC22A1—Neuronal System—HRAS—germ cell cancer	9.75e-06	0.000257	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	9.75e-06	0.000256	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	9.6e-06	0.000253	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—KITLG—germ cell cancer	9.57e-06	0.000252	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—OXT—germ cell cancer	9.4e-06	0.000247	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—H2AFZ—germ cell cancer	9.37e-06	0.000246	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AVP—germ cell cancer	9.35e-06	0.000246	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—OXT—germ cell cancer	9.25e-06	0.000243	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—OXT—germ cell cancer	9.23e-06	0.000243	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—OXT—germ cell cancer	9.2e-06	0.000242	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—OXT—germ cell cancer	9.17e-06	0.000241	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—KITLG—germ cell cancer	9.16e-06	0.000241	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—FGF4—germ cell cancer	9.14e-06	0.00024	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—FGF4—germ cell cancer	9.09e-06	0.000239	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—OXT—germ cell cancer	9.08e-06	0.000239	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—OXT—germ cell cancer	9.06e-06	0.000238	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AVP—germ cell cancer	8.96e-06	0.000236	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—FGF4—germ cell cancer	8.7e-06	0.000229	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—KITLG—germ cell cancer	8.62e-06	0.000227	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CRABP1—germ cell cancer	8.51e-06	0.000224	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AVP—germ cell cancer	8.42e-06	0.000222	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CRABP1—germ cell cancer	8.31e-06	0.000218	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—SLC2A3—germ cell cancer	8.26e-06	0.000217	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—H2AFZ—germ cell cancer	8.16e-06	0.000215	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—SLC22A3—germ cell cancer	8.13e-06	0.000214	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—H2AFZ—germ cell cancer	8.12e-06	0.000214	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.09e-06	0.000213	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—FGF4—germ cell cancer	8.02e-06	0.000211	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—FGF4—germ cell cancer	7.9e-06	0.000208	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—FGF4—germ cell cancer	7.88e-06	0.000207	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—FGF4—germ cell cancer	7.85e-06	0.000207	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—FGF4—germ cell cancer	7.83e-06	0.000206	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CRABP1—germ cell cancer	7.83e-06	0.000206	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—H2AFZ—germ cell cancer	7.77e-06	0.000204	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—FGF4—germ cell cancer	7.75e-06	0.000204	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—FGF4—germ cell cancer	7.73e-06	0.000203	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—FGFR3—germ cell cancer	7.54e-06	0.000198	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—FGFR3—germ cell cancer	7.53e-06	0.000198	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KITLG—germ cell cancer	7.51e-06	0.000198	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KITLG—germ cell cancer	7.47e-06	0.000197	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AVP—germ cell cancer	7.34e-06	0.000193	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AVP—germ cell cancer	7.3e-06	0.000192	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—H2AFZ—germ cell cancer	7.17e-06	0.000189	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KITLG—germ cell cancer	7.15e-06	0.000188	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—FGFR3—germ cell cancer	7.11e-06	0.000187	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—H2AFZ—germ cell cancer	7.05e-06	0.000185	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—H2AFZ—germ cell cancer	7.04e-06	0.000185	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—H2AFZ—germ cell cancer	7.01e-06	0.000184	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—H2AFZ—germ cell cancer	6.99e-06	0.000184	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AVP—germ cell cancer	6.99e-06	0.000184	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—H2AFZ—germ cell cancer	6.92e-06	0.000182	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—KIT—germ cell cancer	6.92e-06	0.000182	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—KIT—germ cell cancer	6.91e-06	0.000182	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—H2AFZ—germ cell cancer	6.9e-06	0.000182	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—FGFR3—germ cell cancer	6.81e-06	0.000179	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CRABP1—germ cell cancer	6.63e-06	0.000174	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KITLG—germ cell cancer	6.59e-06	0.000173	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—KIT—germ cell cancer	6.53e-06	0.000172	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KITLG—germ cell cancer	6.49e-06	0.000171	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KITLG—germ cell cancer	6.47e-06	0.00017	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KITLG—germ cell cancer	6.45e-06	0.00017	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AVP—germ cell cancer	6.44e-06	0.00017	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KITLG—germ cell cancer	6.43e-06	0.000169	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—FGFR3—germ cell cancer	6.4e-06	0.000168	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	6.37e-06	0.000168	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KITLG—germ cell cancer	6.37e-06	0.000168	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KITLG—germ cell cancer	6.35e-06	0.000167	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AVP—germ cell cancer	6.34e-06	0.000167	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AVP—germ cell cancer	6.33e-06	0.000166	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AVP—germ cell cancer	6.31e-06	0.000166	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AVP—germ cell cancer	6.29e-06	0.000165	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	6.28e-06	0.000165	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—KIT—germ cell cancer	6.25e-06	0.000164	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AVP—germ cell cancer	6.23e-06	0.000164	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AVP—germ cell cancer	6.21e-06	0.000163	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—KIT—germ cell cancer	5.88e-06	0.000155	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—FGFR3—germ cell cancer	5.58e-06	0.000147	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—FGFR3—germ cell cancer	5.55e-06	0.000146	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—FGFR3—germ cell cancer	5.31e-06	0.00014	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KIT—germ cell cancer	5.12e-06	0.000135	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CRABP1—germ cell cancer	5.12e-06	0.000135	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KIT—germ cell cancer	5.1e-06	0.000134	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—HRAS—germ cell cancer	5.06e-06	0.000133	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—HRAS—germ cell cancer	5.06e-06	0.000133	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—FGFR3—germ cell cancer	4.9e-06	0.000129	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KIT—germ cell cancer	4.88e-06	0.000128	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—FGFR3—germ cell cancer	4.82e-06	0.000127	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—FGFR3—germ cell cancer	4.81e-06	0.000127	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—FGFR3—germ cell cancer	4.8e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—FGFR3—germ cell cancer	4.78e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—HRAS—germ cell cancer	4.78e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—FGFR3—germ cell cancer	4.73e-06	0.000125	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—FGFR3—germ cell cancer	4.72e-06	0.000124	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—HRAS—germ cell cancer	4.57e-06	0.00012	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KIT—germ cell cancer	4.5e-06	0.000118	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KIT—germ cell cancer	4.43e-06	0.000116	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KIT—germ cell cancer	4.42e-06	0.000116	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KIT—germ cell cancer	4.4e-06	0.000116	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KIT—germ cell cancer	4.39e-06	0.000115	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KIT—germ cell cancer	4.35e-06	0.000114	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KIT—germ cell cancer	4.33e-06	0.000114	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—HRAS—germ cell cancer	4.3e-06	0.000113	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MYC—germ cell cancer	3.81e-06	0.0001	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MYC—germ cell cancer	3.8e-06	0.0001	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—HRAS—germ cell cancer	3.75e-06	9.86e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—HRAS—germ cell cancer	3.73e-06	9.81e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MYC—germ cell cancer	3.59e-06	9.45e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—HRAS—germ cell cancer	3.57e-06	9.39e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MYC—germ cell cancer	3.44e-06	9.05e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HRAS—germ cell cancer	3.29e-06	8.66e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—HRAS—germ cell cancer	3.24e-06	8.52e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—germ cell cancer	3.23e-06	8.51e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HRAS—germ cell cancer	3.23e-06	8.5e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HRAS—germ cell cancer	3.22e-06	8.47e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HRAS—germ cell cancer	3.21e-06	8.45e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HRAS—germ cell cancer	3.18e-06	8.36e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HRAS—germ cell cancer	3.17e-06	8.34e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—germ cell cancer	3.13e-06	8.23e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—germ cell cancer	3.12e-06	8.22e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HRAS—germ cell cancer	2.99e-06	7.87e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HRAS—germ cell cancer	2.99e-06	7.86e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—germ cell cancer	2.95e-06	7.76e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—germ cell cancer	2.83e-06	7.43e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HRAS—germ cell cancer	2.82e-06	7.42e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—germ cell cancer	2.82e-06	7.42e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—germ cell cancer	2.8e-06	7.38e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HRAS—germ cell cancer	2.7e-06	7.11e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—germ cell cancer	2.68e-06	7.06e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—germ cell cancer	2.66e-06	6.99e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HRAS—germ cell cancer	2.54e-06	6.68e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—germ cell cancer	2.48e-06	6.51e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—germ cell cancer	2.44e-06	6.41e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—germ cell cancer	2.43e-06	6.39e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—germ cell cancer	2.42e-06	6.37e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—germ cell cancer	2.41e-06	6.35e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—germ cell cancer	2.39e-06	6.29e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—germ cell cancer	2.38e-06	6.27e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—germ cell cancer	2.32e-06	6.09e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—germ cell cancer	2.3e-06	6.06e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRAS—germ cell cancer	2.21e-06	5.82e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—germ cell cancer	2.21e-06	5.8e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRAS—germ cell cancer	2.2e-06	5.79e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRAS—germ cell cancer	2.11e-06	5.55e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—germ cell cancer	2.03e-06	5.35e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—germ cell cancer	2e-06	5.26e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—germ cell cancer	2e-06	5.25e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—germ cell cancer	1.99e-06	5.23e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—germ cell cancer	1.98e-06	5.22e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—germ cell cancer	1.96e-06	5.17e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—germ cell cancer	1.96e-06	5.15e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRAS—germ cell cancer	1.94e-06	5.11e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRAS—germ cell cancer	1.91e-06	5.03e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRAS—germ cell cancer	1.91e-06	5.02e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRAS—germ cell cancer	1.9e-06	5.01e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRAS—germ cell cancer	1.9e-06	4.99e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRAS—germ cell cancer	1.88e-06	4.94e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRAS—germ cell cancer	1.87e-06	4.93e-05	CbGpPWpGaD
